HLA CLASS I-DEFICIENT NK-92 CELLS WITH DECREASED IMMUNOGENICITY

摘要

Described herein are modified NK-92 cells comprising a genetic alteration to decrease beta-2-microglobulin (B2M) expression in NK-92 cells to reduce the levels of HLA class I expression; methods of generating such cells; and methods of treating a subject, e.g., that has cancer, with the B2M-modified NK-92 cells.